|Articles|November 1, 2003
MEASURING MELASMA'S IMPACT
Researchers from the departments of dermatology at Wake Forest University Health Sciences and at the University of California, San Francisco, have developed a way to measure the impact that melasma has on health-related quality of life (HRQoL).
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Oruka Reports Positive Interim Phase 1 Data for ORKA-002, Advances ORKA-001
2
Recludix Pharma’s REX-8756 for Type 2 Inflammatory Diseases Enters First Human Trials
3
Alpha Tau Submits First PMA Module to FDA for Novel cSCC Treatment, Alpha DaRT
4
Expert Panel Provides Clinical Guidance for the Use of Trifarotene in Malaysian Acne Care
5














